Revascularization Strategies in STEMI with Multivessel Disease: Deciding on Culprit Versus Complete—Ad Hoc or Staged

Author:

Patel Shalin,Bailey Steven R.

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Reference53 articles.

1. de Boer SP, Barnes EH, Westerhout CM, et al. High-risk patients with ST-elevation myocardial infarction derive greatest absolute benefit from primary percutaneous coronary intervention results from the Primary Coronary Angioplasty Trialist versus Thrombolysis (PCAT)-2 Collaboration. Am Heart J. 2011;161(3):500–7.

2. • Muller DW, Topol EJ, Ellis SG, Sigmon KN, Lee K, Califf RM. Multivessel coronary artery disease: a key predictor of short-term prognosis after reperfusion therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) study group. Am Heart J. 1991;121(Pt 1):1042–9. This study is an early multicenter, multi study investigation that evaluated the impact of multIvessel disease (MVD) in patients who received thrombolysis. MVD patients had more risk factors and lower ejection fractions even after successful thrombolysis

3. Kahn JK, Rutherford BD, McConahay DR, et al. Results of primary angioplasty for acute myocardial infarction in patients with multivessel coronary artery disease. J Am Coll Cardiol. 1990;16:1089–96.

4. Muller DW, Topol EJ, Ellis SG, et al. Determinants of the need for early acute intervention in patients treated conservatively after thrombolytic therapy for acute myocardial infarction. Tami-5 study group. J Am Coll Cardiol. 1991;18:1594–601.

5. Park DW, Clare RM, Schulte PJ, et al. Extent, location, and clinical significance of non-infarct related coronary artery disease among patients with ST-elevation myocardial infarction. JAMA. 2014;312:2019–27.

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3